Since 2006, 146 VC-backed companies have been founded or co-founded by females who attended Stanford; Harvard and UC Berkeley come next in line with 115 each. Here's a closer look at the top 10 undergraduate programs for female founders:
Several highly valued startups have come out of the schools sitting at the top of the rankings. Here's a roundup of notable VC-backed companies founded by women who've attended the top three undergraduate schools:
Stanford: LeverHQ: San Francisco | VC funding: $60 million | Valuation: $200 million (July 2017)
Sarah Nahm founded Lever in 2012 as a recruiting platform. The startup, which provides software to help companies grow their teams, has raised funding from backers including Adams Street Partners and Matrix Partners. Nahm (pictured) received a bachelor's degree in product design and mechanical engineering from Stanford, then worked at Google for several years before starting her own company.
Harvard: Rent the RunwayHQ: New York | VC funding: $176 million | Valuation: $750 million (Dec. 2016)
Rent the Runway, a designer clothing and accessory rental service, is one of the most well-known female-founded startups. The company was co-founded and is currently led by Jennifer Hyman, who graduated with a bachelor's degree from Harvard in 2002 and completed her MBA from Harvard Business School in 2009. The startup's other founder, Jennifer Fleiss, attended Yale (No. 9 on the undergraduate list). Hyman (pictured) and Fleiss launched Rent the Runway out of Harvard Business School, which has more female founders than any other MBA program.
UC Berkeley: Millendo TherapeuticsHQ: Ann Arbor, MI | VC funding: $81 million | Valuation: $96.5 million (Dec. 2015)
In the years before she co-founded Millendo Therapeutics, Julia Owens (pictured) earned a bachelor's degree in chemistry and molecular & cellular biology from UC Berkeley, then went on to receive a PhD in biochemistry from UC San Francisco before working for a few different pharmaceutical companies. Millendo is a biotech focused on developing treatments for endocrine diseases. The startup has raised funding from investors including NEA, Altitude Life Science Ventures and Roche Venture Fund.